{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:00:44Z","timestamp":1792098044952,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T00:00:00Z","timestamp":1262736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00210-009-0484-y","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T01:36:07Z","timestamp":1262655367000},"page":"137-145","source":"Crossref","is-referenced-by-count":30,"title":["Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca2+-mediated calcineurin and CaMKII signaling pathways"],"prefix":"10.1007","volume":"381","author":[{"given":"Zhen-Wei","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hua","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,6]]},"reference":[{"key":"484_CR1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.biocel.2008.02.020","volume":"40","author":"SP Barry","year":"2008","unstructured":"Barry SP, Davidson SM, Townsend PA (2008) Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol 40:2023\u20132039","journal-title":"Int J Biochem Cell Biol"},{"key":"484_CR2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1196\/annals.1341.008","volume":"1047","author":"DM Bers","year":"2005","unstructured":"Bers DM, Guo T (2005) Calcium signaling in cardiac ventricular myocytes. Ann N Y Acad Sci 1047:86\u201398","journal-title":"Ann N Y Acad Sci"},{"key":"484_CR3","doi-asserted-by":"crossref","first-page":"24194","DOI":"10.1074\/jbc.M802869200","volume":"283","author":"AY Chan","year":"2008","unstructured":"Chan AY, Dolinsky VW, Soltys CL, Viollet B, Baksh S, Light PE, Dyck JR (2008) Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem 283:24194\u201324201","journal-title":"J Biol Chem"},{"key":"484_CR4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCRESAHA.107.155721","volume":"101","author":"E Cingolani","year":"2007","unstructured":"Cingolani E, Ramirez Correa GA, Kizana E, Murata M, Cho HC, Marban E (2007) Gene therapy to inhibit the calcium channel beta subunit: physiological consequences and pathophysiological effects in models of cardiac hypertrophy. Circ Res 101:166\u2013175","journal-title":"Circ Res"},{"key":"484_CR5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1292\/jvms.71.737","volume":"71","author":"JJ Han","year":"2009","unstructured":"Han JJ, Hao J, Kim CH, Hong JS, Ahn HY, Lee YS (2009) Quercetin prevents cardiac hypertrophy induced by pressure overload in rats. J Vet Med Sci 71:737\u2013743","journal-title":"J Vet Med Sci"},{"key":"484_CR6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589\u2013600","journal-title":"Nat Rev Mol Cell Biol"},{"key":"484_CR7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.RES.87.10.937","volume":"87","author":"T Kato","year":"2000","unstructured":"Kato T, Sano M, Miyoshi S, Sato T, Hakuno D, Ishida H, Kinoshita-Nakazawa H, Fukuda K, Ogawa S (2000) Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats. Circ Res 87:937\u2013945","journal-title":"Circ Res"},{"key":"484_CR8","doi-asserted-by":"crossref","first-page":"13367","DOI":"10.1074\/jbc.273.22.13367","volume":"273","author":"CB Klee","year":"1998","unstructured":"Klee CB, Ren H, Wang X (1998) Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 273:13367\u201313370","journal-title":"J Biol Chem"},{"key":"484_CR9","doi-asserted-by":"crossref","first-page":"18F","DOI":"10.1016\/S0002-9149(02)03336-2","volume":"91","author":"L Klein","year":"2003","unstructured":"Klein L, O'Connor CM, Gattis WA, Zampino M, de Luca L, Vitarelli A, Fedele F, Gheorghiade M (2003) Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am J Cardiol 91:18F\u201340F","journal-title":"Am J Cardiol"},{"key":"484_CR10","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.biocel.2008.03.002","volume":"40","author":"MV Latronico","year":"2008","unstructured":"Latronico MV, Elia L, Condorelli G, Catalucci D (2008) Heart failure: targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment. Int J Biochem Cell Biol 40:1643\u20131648","journal-title":"Int J Biochem Cell Biol"},{"key":"484_CR11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/jcb.22038","volume":"106","author":"KS Lee","year":"2009","unstructured":"Lee KS, Park JH, Lee S, Lim HJ, Park HY (2009) PPARdelta activation inhibits angiotensin II induced cardiomyocyte hypertrophy by suppressing intracellular Ca2+ signaling pathway. J Cell Biochem 106:823\u2013834","journal-title":"J Cell Biochem"},{"key":"484_CR12","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561\u20131566","journal-title":"N Engl J Med"},{"key":"484_CR13","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.freeradbiomed.2006.01.005","volume":"40","author":"HL Li","year":"2006","unstructured":"Li HL, Huang Y, Zhang CN, Liu G, Wei YS, Wang AB, Liu YQ, Hui RT, Wei C, Williams GM, Liu DP, Liang CC (2006) Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med 40:1756\u20131775","journal-title":"Free Radic Biol Med"},{"key":"484_CR14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1055\/s-2004-832644","volume":"70","author":"XL Li","year":"2004","unstructured":"Li XL, Li YQ, Yan WM, Li HY, Xu H, Zheng XX, Guo DW, Tang LK (2004) A study of the cardioprotective effect of breviscapine during hypoxia of cardiomyocytes. Planta Med 70:1039\u20131044","journal-title":"Planta Med"},{"key":"484_CR15","doi-asserted-by":"crossref","first-page":"H1703","DOI":"10.1152\/ajpheart.00238.2001","volume":"282","author":"Y Liao","year":"2002","unstructured":"Liao Y, Ishikura F, Beppu S, Asakura M, Takashima S, Asanuma H, Sanada S, Kim J, Ogita H, Kuzuya T, Node K, Kitakaze M, Hori M (2002) Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation. Am J Physiol Heart Circ Physiol 282:H1703\u2013H1708","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"484_CR16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0195-668X(02)00829-1","volume":"24","author":"DJ Lips","year":"2003","unstructured":"Lips DJ, deWindt LJ, van Kraaij DJ, Doevendans PA (2003) Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur Heart J 24:883\u2013896","journal-title":"Eur Heart J"},{"key":"484_CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","volume":"93","author":"JD Molkentin","year":"1998","unstructured":"Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215\u2013228","journal-title":"Cell"},{"key":"484_CR18","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/ptr.2364","volume":"22","author":"Z Pan","year":"2008","unstructured":"Pan Z, Feng T, Shan L, Cai B, Chu W, Niu H, Lu Y, Yang B (2008) Scutellarin-induced endothelium-independent relaxation in rat aorta. Phytother Res 22:1428\u20131433","journal-title":"Phytother Res"},{"key":"484_CR19","doi-asserted-by":"crossref","first-page":"C992","DOI":"10.1152\/ajpcell.00594.2008","volume":"296","author":"AM Prasad","year":"2009","unstructured":"Prasad AM, Inesi G (2009) Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes. Am J Physiol Cell Physiol 296:C992\u2013C1002","journal-title":"Am J Physiol Cell Physiol"},{"key":"484_CR20","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1096\/fasebj.6.6.1531968","volume":"6","author":"H Rupp","year":"1992","unstructured":"Rupp H, Elimban V, Dhalla NS (1992) Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J 6:2349\u20132353","journal-title":"FASEB J"},{"key":"484_CR21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/aps.2009.95","volume":"30","author":"M Wang","year":"2009","unstructured":"Wang M, Zhang WB, Zhu JH, Fu GS, Zhou BQ (2009) Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway. Acta Pharmacol Sin 30:1081\u20131091","journal-title":"Acta Pharmacol Sin"},{"key":"484_CR22","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbrc.2004.07.121","volume":"322","author":"BJ Wilkins","year":"2004","unstructured":"Wilkins BJ, Molkentin JD (2004) Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322:1178\u20131191","journal-title":"Biochem Biophys Res Commun"},{"key":"484_CR23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nm1569","volume":"13","author":"B Yang","year":"2007","unstructured":"Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13:486\u2013491","journal-title":"Nat Med"},{"key":"484_CR24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cardiores.2004.04.026","volume":"63","author":"T Zhang","year":"2004","unstructured":"Zhang T, Brown JH (2004) Role of Ca2+\/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res 63:476\u2013486","journal-title":"Cardiovasc Res"},{"key":"484_CR25","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1074\/jbc.M108525200","volume":"277","author":"T Zhang","year":"2002","unstructured":"Zhang T, Johnson EN, Gu Y, Morissette MR, Sah VP, Gigena MS, Belke DD, Dillmann WH, Rogers TB, Schulman H, Ross J Jr, Brown JH (2002) The cardiac-specific nuclear delta(B) isoform of Ca2+\/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 277:1261\u20131267","journal-title":"J Biol Chem"},{"key":"484_CR26","doi-asserted-by":"crossref","first-page":"15239","DOI":"10.1074\/jbc.275.20.15239","volume":"275","author":"W Zhu","year":"2000","unstructured":"Zhu W, Zou Y, Shiojima I, Kudoh S, Aikawa R, Hayashi D, Mizukami M, Toko H, Shibasaki F, Yazaki Y, Nagai R, Komuro I (2000) Ca2+\/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J Biol Chem 275:15239\u201315245","journal-title":"J Biol Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-009-0484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-009-0484-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-009-0484-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:02:23Z","timestamp":1558627343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-009-0484-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1007\/s00210-009-0484-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,6]]}}}